IMMUNOGEN INC - COMMON STOCK (IMGN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
IMGN
Price per share
$269.00
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1
Total reported value
$269
Share change
0
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 1 institutional investors reported holding 1 shares of IMMUNOGEN INC - COMMON STOCK (IMGN).

Institutional Holders of IMMUNOGEN INC - COMMON STOCK (IMGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1 $269 $269.00 1
2025 Q3 1 $269 $269.00 1
2025 Q2 1 $269 $269.00 1
2025 Q1 1 $269 $269.00 1
2024 Q4 1 $269 $269.00 1
2024 Q3 1 $269 $269.00 1
2024 Q2 1 $31 -$59,396 $31.00 1
2024 Q1 893 $27,761 -$7,522,571,671 $31.00 3
2023 Q4 254,094,050 $7,533,999,824 +$401,339,258 $29.65 326
2023 Q3 246,454,885 $3,911,227,602 +$257,146,887 $15.87 276
2023 Q2 224,551,519 $4,237,141,822 +$343,848,874 $18.87 264
2023 Q1 210,134,362 $806,046,933 +$5,739,854 $3.84 187
2022 Q4 204,686,288 $1,015,224,276 +$15,852,646 $4.96 198
2022 Q3 196,733,103 $940,400,518 +$7,046,885 $4.78 202
2022 Q2 196,092,107 $882,406,823 +$7,352,086 $4.50 197
2022 Q1 194,501,818 $924,831,254 -$12,112,857 $4.76 200
2021 Q4 189,754,200 $1,407,026,080 +$89,029,135 $7.42 214
2021 Q3 176,648,627 $1,001,871,527 -$25,186,396 $5.67 201
2021 Q2 180,668,821 $1,190,571,826 -$26,866,259 $6.59 195
2021 Q1 182,687,155 $1,479,725,302 +$74,532,731 $8.10 203
2020 Q4 173,709,826 $1,120,464,336 +$212,001,470 $6.45 197
2020 Q3 142,008,985 $511,237,055 +$6,612,840 $3.60 165
2020 Q2 139,175,703 $640,170,630 +$17,620,182 $4.60 175
2020 Q1 137,178,692 $467,794,385 +$82,382,310 $3.41 169
2019 Q4 111,809,273 $567,678,267 +$41,943,730 $5.10 174
2019 Q3 103,982,410 $251,586,634 +$5,492,886 $2.42 164
2019 Q2 102,051,776 $221,128,288 -$29,615,975 $2.17 166
2019 Q1 117,682,098 $318,624,822 -$28,869,908 $2.71 182
2018 Q4 122,756,981 $588,847,064 -$60,802,727 $4.80 177
2018 Q3 124,766,837 $1,181,528,261 -$9,871,259 $9.47 188
2018 Q2 125,723,455 $1,223,252,651 +$198,903,783 $9.73 183
2018 Q1 104,934,056 $1,103,855,950 +$31,576,229 $10.52 193
2017 Q4 103,884,846 $665,949,340 +$83,951,114 $6.41 182
2017 Q3 90,282,460 $690,629,199 +$108,864,763 $7.65 169
2017 Q2 76,168,455 $541,547,835 +$63,586,322 $7.11 147
2017 Q1 67,598,721 $261,589,769 +$26,227,730 $3.87 122
2016 Q4 66,971,713 $136,614,635 -$18,795,271 $2.04 140
2016 Q3 75,431,853 $201,946,041 -$17,035,141 $2.68 137
2016 Q2 81,532,810 $251,080,099 +$1,581,580 $3.08 139
2016 Q1 77,027,993 $656,394,142 -$9,499,906 $8.52 138
2015 Q4 77,614,965 $1,053,239,260 +$2,552,467 $13.57 145
2015 Q3 77,716,380 $746,150,091 -$4,514,138 $9.60 144
2015 Q2 78,867,330 $1,134,054,269 +$87,968,575 $14.38 135
2015 Q1 74,117,079 $662,816,260 +$49,520,429 $8.95 132
2014 Q4 69,292,924 $422,665,502 -$92,941,856 $6.10 127
2014 Q3 75,100,804 $795,229,916 +$13,273,482 $10.59 138
2014 Q2 73,805,446 $874,504,384 -$33,989,744 $11.85 135
2014 Q1 76,361,856 $1,139,805,895 +$14,032,171 $14.93 137